Avanos Medical, Inc. (AVNS)
| Market Cap | 2.23B |
| Revenue (ttm) | 714.80M |
| Net Income (ttm) | -27.20M |
| Shares Out | 47.83M |
| EPS (ttm) | -0.57 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 5 |
| Last Price | $46.55 |
| Previous Close | $44.38 |
| Change ($) | 2.17 |
| Change (%) | 4.89% |
| Day's Open | 45.29 |
| Day's Range | 44.44 - 46.72 |
| Day's Volume | 232,276 |
| 52-Week Range | 19.46 - 53.61 |
Investor confidence is high in Avanos Medical (AVNS) stock, courtesy of its solid prospects.
ALPHARETTA, Ga., Feb. 24, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present at the Vi...
Avanos Medical (AVNS) continues to gain from its core Chronic Care segment in the fourth quarter.
Avanos Medical (AVNS) delivered earnings and revenue surprises of 27.27% and 0.67%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Avanos Medical (NYSE:AVNS) rose 0.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 17.65% year over year to $0.28, which...
Investor confidence is high on Avanos Medical (AVNS), courtesy of solid prospects.
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
ALPHARETTA, Ga., Nov. 5, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in November: Conference:...
Avanos Medical (AVNS) continued to gain from core Chronic Care segment in the third quarter.
Avanos Medical's (AVNS) CEO Joe Woody on Q3 2020 Results - Earnings Call Transcript
Avanos Medical (AVNS) delivered earnings and revenue surprises of 50.00% and 11.94%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the st...
ALPHARETTA, Ga., Nov. 3, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2020 financial results. "Thanks to the work of our team and their focus on executio...
ALPHARETTA, Ga., Oct. 27, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 202...
Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.
ALPHARETTA, Ga., Sept. 15, 2020 /PRNewswire/ -- Avanos Medical, Inc.
ALPHARETTA, Ga., Sept. 4, 2020 /PRNewswire/ -- Avanos Medical, Inc.
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
ALPHARETTA, Ga., Sept. 3, 2020 /PRNewswire/ -- Avanos Medical, Inc.
Avanos Medical, Inc. Appoints Bill Haydon as Senior Vice President & General Manager, Pain Franchise
ALPHARETTA, Ga., Aug. 31, 2020 /PRNewswire/ -- Avanos Medical, Inc.
Avanos Medical's (AVNS) second-quarter results benefit from contribution from Chronic Care segment.
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q2 2020 Results - Earnings Call Transcript
Avanos Medical (AVNS) delivered earnings and revenue surprises of 262.50% and 10.19%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
ALPHARETTA, Ga., Aug. 4, 2020 /PRNewswire/ -- Avanos Medical, Inc.
Avanos Medical (AVNS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
ALPHARETTA, Ga., May 28, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in June: Conference: Jef...
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q1 2020 Results - Earnings Call Transcript
Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.
Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.88% and 4.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.
Avanos (AVNS) gains from segmental contributions in Q4.
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q4 2019 Results - Earnings Call Transcript
Avanos Medical (AVNS) delivered earnings and revenue surprises of 6.25% and 6.73%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Avanos (AVNS) third-quarter results benefit from higher revenues and strong segmental performance.
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q3 2019 Results - Earnings Call Transcript
Shares slump after the company reports weak third-quarter results and cuts guidance. Here's what investors need to know.
Avanos Medical (AVNS) delivered earnings and revenue surprises of -6.25% and -5.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the st...
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avanos Medical (AVNS) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Avanos (AVNS) second-quarter results benefit from higher revenues, strong segmental performance and expansion in margins.
Avanos Medical's (AVNS) CEO Joe Woody on Q2 2019 Results - Earnings Call Transcript
Avanos Medical (AVNS) delivered earnings and revenue surprises of 12.00% and -0.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avanos (AVNS) Q1 results benefit from higher revenues, strong segmental performance and expansion in margins.
Avanos Medical, Inc. (AVNS) CEO Joseph Woody on Q1 2019 Results - Earnings Call Transcript
About AVNS
Avanos Medical operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devic... [Read more...]
| Industry Medical Devices | |
| CEO Joseph Woody | Employees 5,380 |
| Stock Exchange NYSE | Ticker Symbol AVNS |
Financial Performance
In 2020, Avanos Medical's revenue was $714.80 million, an increase of 2.47% compared to the previous year's $697.60 million. Losses were -$27.20 million, -40.74% less than in 2019.
Analyst Forecasts
According to 7 analysts, the average rating for Avanos Medical stock is "Buy." The 12-month stock price forecast is 52.00, which is an increase of 11.71% from the latest price.